The challenge of recruiting patients into a placebo-controlled surgical trial

Trials

Ewa M Roos²  L Stefan Lohmander¹  Kristoffer B Hare³ 

[1] Department of Orthopedics, Clinical Sciences Lund, University of Lund, Paradisgatan 2, 221 00 Lund, Sweden;Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark;Department of Orthopedics, Slagelse Hospital, Ingemannsvej 18, 4200 Slagelse, Region Zealand, Denmark

关键词: Trial;    Recruitment;    Surgery;    Placebo;    Feasibility;   

Others  :  806250
DOI  :  10.1186/1745-6215-15-167

 received in 2013-12-14, accepted in 2014-04-30,  发布年份 2014

【 摘 要 】

Background

Randomized placebo-controlled trials represent the gold standard in evaluating healthcare interventions but are rarely performed within orthopedics. Ethical concerns or well-known challenges in recruiting patients for surgical trials in general have been expressed and adding a placebo component only adds to this complexity. The purpose of this study was to report the challenges of recruiting patients into an orthopedic placebo-controlled surgical trial, to determine the number of patients needed to be screened and allocated in order to include one participant into the trial, and to identify reasons associated with participation in a placebo-controlled randomized surgical trial.

Methods

Data were extracted from an ongoing placebo-controlled randomized controlled trial (RCT) on meniscectomy versus placebo surgery. We calculated the number of patients needed to be screened in order to include the required number of participants into the RCT. Participating patients were asked about their rationale for joining the study and which type of information was most useful for deciding upon participation.

Results

A total of 476 patients entered the screening group, of which 190 patients fulfilled the inclusion and exclusion criteria. 102 patients declined to participate in the study due to various reasons and 46 were later excluded (no meniscus lesion on the magnetic resonance imaging scan or withdrawn consent). A total of 40 patients were finally included in the RCT. To include one patient into the RCT, 11.9 individuals needed to be screened. A total of 69% of participating patients considered the oral information to be the most important and the most common reason for participating was the contribution to research (90%).

Conclusions

Patients are willing to participate in an orthopedic placebo-controlled surgical trial. Oral information given by the surgeon to the patient and the contribution to research are important aspects to enhance patient recruitment.

Trial registration

ClinicalTrials.gov NCT01264991, registered 21 December 2010.

【 授权许可】

   
2014 Hare et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Armitage P: The role of randomization in clinical trials. Stat Med 1982, 1:345-352.
• [2]London AJ, Kadane JB: Placebo that harms: sham surgery controls in clinical trials. Stat Methods Med Res 2002, 11:413-427.
• [3]Macklin R: The ethical problems of sham surgery in clinical trials. N Engl J Med 1999, 341:992-996.
• [4]Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien P-A, Reeves BC, Seiler CM: Challenges in evaluating surgical innovation. Lancet 2009, 374:1097-1104.
• [5]McLeod RS: Issues in surgical randomized controlled trials. World J Surg 1999, 23:1210-1214.
• [6]Campbell MK, Entwistle VA, Cuthbertson BH, Skea ZC, Sutherland AG, McDonald AM, Norrie JD, Carlson RV, Bridgman S: Developing a placebo-controlled trial in surgery: issues of design, acceptability and feasibility. Trials 2011, 12:50. BioMed Central Full Text
• [7]Frobell R, Lohmander L, Roos E: The challenge of recruiting patients with anterior cruciate ligament injury of the knee into a randomized clinical trial comparing surgical and non-surgical treatment. Contemp Clin Trials 2007, 28:295-302.
• [8]Moseley JB, O’Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP: A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002, 347:81-88.
• [9]Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt CJ, Graves SE, Staples MP, Murphy B: A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009, 361:557-568.
• [10]Sihvonen R, Paavola M, Malmivaara A, Itälä A, Joukainen A, Nurmi H, Kalske J, Järvinen TLN: Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med 2013, 369:2515-2524.
• [11]Cullen K, Hall M, Golosinskiy A: Ambulatory surgery in the United States, 2006. Nat Health Stat Rep Nat Cent Health Stat 2009, 11:1-28.
• [12]Katz JN, Brophy RH, Chaisson CE, de Chaves L, Cole BJ, Dahm DL, Donnell-Fink LA, Guermazi A, Haas AK, Jones MH, Levy BA, Mandl LA, Martin SD, Marx RG, Miniaci A, Matava MJ, Palmisano J, Reinke EK, Richardson BE, Rome BN, Safran-Norton CE, Skoniecki DJ, Solomon DH, Smith MV, Spindler KP, Stuart MJ, Wright J, Wright RW, Losina E: Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med 2013, 368:1675-1684.
• [13]Herrlin S, Hållander M, Wange P, Weidenhielm L, Werner S: Arthroscopic or conservative treatment of degenerative medial meniscal tears: a prospective randomized trial. Knee Surg Sports Traumatol Arthrosc 2007, 15:393-401.
• [14]Kirkley A, Birmingham TB, Litchfield RB, Giffin R, Willits KR, Wong CJ, Feagan BG, Donner A, Griffin SH, D’Ascanio LM, Pope JE, Fowler PJ: A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2008, 359:1097-1107.
• [15]Englund M: The role of the meniscus in osteoarthritis genesis. Rheum Dis Clin N Am 2008, 34:573-579.
• [16]Englund M, Guermazi A, Roemer FW, Aliabadi P, Yang M, Lewis CE, Torner J, Nevitt MC, Sack B, Felson DT: Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: The multicenter osteoarthritis study. Arthritis Rheum 2009, 60:831-839.
• [17]Englund M, Lohmander LS: Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy. Arthritis Rheum 2004, 50:2811-2819.
• [18]Hare KB, Lohmander LS, Christensen R, Roos EM: Arthroscopic partial meniscectomy in middle-aged patients with mild or no knee osteoarthritis: a protocol for a double-blind, randomized sham-controlled multi-centre trial. BMC Musculoskelet Disord 2013, 14:1. BioMed Central Full Text
• [19]Rembold CM: Number needed to screen: development of a statistic for disease screening. BMJ 1998, 317:307-312.
• [20]Nelson HD, Helfand M, Woolf SH, Allan JD: Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. preventive service task force. Ann Intern Med 2002, 137:529-541.
• [21]Sharp L, Cotton SC, Alexander L, Williams E, Gray NM, Reid JM: Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Clin Trials 2006, 3:431-442.
• [22]Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R: Barriers to participation in randomized controlled trials: a systematic review. J Clin Epidemiol 1999, 52:1143-1156.
• [23]Prescott RJ, Counsell CE, Gillespie WJ, Grant AM, Russell IT, Kiauka S, Colthart IR, Ross S, Shepherd SM, Russell D: Factors that limit the quality, number and progress of randomized controlled trials. Health Technol Assess 1999, 3:1-143.
• [24]Hegedus EJ: Physical examination tests for assessing a torn meniscus in the knee: a systematic review with meta-analysis. J Orthop Sports Phys Ther 2007, 37:541-550.
• [25]Englund M, Guermazi A, Gale D, Hunter DJ, Aliabadi P, Clancy M, Felson DT: Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med 2008, 359:1108-1115.
• [26]Frobell R, Roos EM, Roos HP, Ranstam J, Lohmander LS: A randomized trial of treatment for acute anterior cruciate ligament tears. N Engl J Med 2010, 363:331-342.
• [27]Cook JA, McCulloch P, Blazeby JM, Beard DJ, Marinac-Dabic D, Sedrakyan A: IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 2013, 346:f2820.